Notice of Results
April 22 2003 - 3:01AM
UK Regulatory
BW20030421002059 20030422T060140Z UTC
( BW)(IVAX-CORPORATION)(IVX) Notice of Results
Business Editors
UK REGULATORY NEWS
MIAMI--(BUSINESS WIRE)--April 22, 2003--
IVAX Announces First Quarter 2003 Financial Results Release Date
And Conference Call Access Information
IVAX Corporation (AMEX:IVX) (LSE:IVX.L) plans to release its first
quarter 2003 financial results on Thursday, April 24th before the U.S.
securities markets open. The company will then conduct a conference
call at 10:00 a.m. Eastern (Miami) Time to discuss first quarter
results as well as other topics.
Interested parties can access the conference call by dialing
1-888-423-3276 from anywhere in the U.S. or by dialing 612-332-0226
from non-U.S. locations. The conference call will also be webcast. To
access the webcast, go to IVAX' web site at http://www.ivax.com and
click on the webcast link on the home page at least 15 minutes before
the call begins to register and download or install any necessary
software.
A replay of the conference call will be available on April 24th
starting at approximately 1:30 p.m. through May 1st. To listen to the
replay, dial 1-800-475-6701 and enter ID # 682679. A replay of the
webcast will also be available starting April 24th through May 1st.
IVAX Corporation, headquartered in Miami, Florida, discovers,
develops, manufactures, and markets branded and brand equivalent
(generic) pharmaceuticals and veterinary products in the U.S. and
internationally.
Copies of this and other news releases may be obtained free of charge
from IVAX' web site at http://www.ivax.com.
Short Name: IVAX Corporation
Category Code: NOR
Sequence Number: 00004145
Time of Receipt (offset from UTC): 20030421T194112+0100
--30--GAA/mi* DB/ny
CONTACT: IVAX Corporation, Miami
Jim Whitlow, 305/575-6043
KEYWORD: FLORIDA UNITED KINGDOM INTERNATIONAL EUROPE
INDUSTRY KEYWORD: PHARMACEUTICAL CONFERENCE CALLS
SOURCE: IVAX Corporation
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.
URL: http://www.businesswire.com